Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Calcutt

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
General Pharmacology|January 1, 1976
The role of histamine in the brainC R Calcutt
Neuroscience|August 1, 1983
Histamine and the hypothalamusF Roberts, C R Calcutt
British Journal of Pharmacology|February 1, 1971
Activities of narcotic and narcotic-antagonist analgesics following the intraventricular injection of various substancesC R Calcutt, P S Spencer
Psychopharmacologia|January 1, 1971
Modification of the anti-nociceptive activity of morphine by centrally administered Ouabain and DopamineC R Calcutt, N S Doggett, P S Spencer
European Journal of Pharmacology|January 6, 1987
Evidence for low brain penetration by the H1-receptor antagonist temelastine (SK&F 93944)C R Calcutt, C R Ganellin, B Jackson, et al.
British Journal of Pharmacology|January 1, 1988
Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonistC R Calcutt, C R Ganellin, R Griffiths, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
General Pharmacology|January 1, 1976
The role of histamine in the brainC R Calcutt
Neuroscience|August 1, 1983
Histamine and the hypothalamusF Roberts, C R Calcutt
British Journal of Pharmacology|February 1, 1971
Activities of narcotic and narcotic-antagonist analgesics following the intraventricular injection of various substancesC R Calcutt, P S Spencer
Psychopharmacologia|January 1, 1971
Modification of the anti-nociceptive activity of morphine by centrally administered Ouabain and DopamineC R Calcutt, N S Doggett, P S Spencer
European Journal of Pharmacology|January 6, 1987
Evidence for low brain penetration by the H1-receptor antagonist temelastine (SK&F 93944)C R Calcutt, C R Ganellin, B Jackson, et al.
British Journal of Pharmacology|January 1, 1988
Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonistC R Calcutt, C R Ganellin, R Griffiths, et al.
Pageof 1